ABSTRACT: Subacute ruminal acidosis can result in increased flow of fermentable substrates to the hindgut, which can negatively affect animal health and productivity. However, animal responses to increased hindgut fermentation independent of subacute ruminal acidosis have rarely been evaluated. This study determined the impact of abomasal dosage of a fermentable carbohydrate on animal performance and blood and fecal variables. Six ruminally cannulated Holstein steers fed a lactating dairy cow ration were used in a crossover design study with 14-d periods. On d 13 of each period, steers were infused abomasally with a pulse dose of 0 (control) or 1 (Oligo) g of oligofructose/kg of BW. Blood samples collected at 0, 3, 6, 9, 12, and 24 h after abomasal oligofructose dose were evaluated for metabolites (blood urea N, β-hydroxybutyric acid, and NEFA) and systemic inflammatory markers (Cu, serum amyloid A, and haptoglobin). Fecal samples, rectal temperature, heart rate, and respiratory rate were taken at 0, 3, 6, 9, 12, 24, and 48 h after abomasal dosage. Fecal samples were assayed for pH, DM percentage, consistency score (1 = liquid to 5 = coarse), and organic acid concentrations. Data were evaluated using a model including the fixed effects of treatment, time after dosage, and their interaction. Effects of treatment or treatment × time were not significant for DMI, blood variables, rectal temperature, or respiratory rate. Fecal pH was slightly reduced for Oligo compared with control steers (6.76 vs. 7.02; P = 0.04). A treatment × time interaction occurred for fecal DM (P < 0.001). Compared with control steers, DM content of feces was reduced in Oligo steers at 6 h (12.6 vs. 15.2%) but increased at 9 h (16.3 vs. 15.0%) and 12 h (16.5 vs. 15.0). Fecal consistency score was reduced by the Oligo treatment at 6 h (1.44 vs. 2.83; P < 0.001) and 9 h (1.83 vs. 2.67; P = 0.005). A treatment × time interaction was detected for fecal concentrations of lactate and acetate (P < 0.05) and tended to occur for propionate and butyrate (P < 0.10). The greatest difference for all organic acids occurred at 12 h, when fecal concentrations of lactate, acetate, propionate, and butyrate were 0.5, 47, 11, and 4.0 mM in control steers and 5.3, 76, 15, and 6.8 mM in Oligo steers, respectively. In summary, abomasal dosage of 1 g of oligofructose/kg of BW increased fecal excretion of microbial fermentation products in steers without causing metabolic acidosis, metabolic disruption, or inflammation.
INTRODUCTION
In healthy cattle, the large intestine is responsible for an average of 4.5% of total tract starch disappearance and 6.7% of total tract OM disappearance, though results vary substantially among trials (Gressley et al., 2011) . Dietary and environmental conditions that contribute to subacute ruminal acidosis (SARA) may also lead to increased carbohydrate fermentation in the large intestine. For example, changes in fecal consistency in response to increased hindgut fermentation (e.g., diarrhea, frothy feces, and presence of mucin casts) are used as field indicators of SARA (Hall, 2002; Plaizier et al., 2008) .
Few studies have evaluated the effects of increased hindgut fermentation independent of SARA; however, studies in sheep and cows have demonstrated that continuous postruminal glucose or starch infusions induced fecal changes. These changes included decreased DM (Thornton et al., 1970; Bissell, 2002) , increased microbial output (Ørskov et al., 1970; Surra et al., 1997; Reynolds et al., 2001) , increased VFA concentrations (Ørskov et al., 1970) , and decreased pH (Reynolds et al., 2001; Bissell, 2002) .
The objective of this experiment was to evaluate the effects of pulse-dose abomasal delivery of 0 or 1 g of oligofructose/kg of BW in Holstein steers. Indicators of metabolic acidosis (heart rate, respiratory rate, rectal temperature, and blood pH), metabolic disruption [blood urea N, β-hydroxybutyric acid (BHBA), and NEFA], acute phase inflammatory response (blood se-rum amyloid A, haptoglobin, and Cu), and intestinal fermentation (fecal pH, DM, consistency, lactate, and VFA) were quantified over time after the dosage. We hypothesized that abomasal dosage of 1 g of oligofructose/kg of BW of would increase intestinal fermentation and result in metabolic acidosis, metabolic disruption, and inflammation.
MATERIALS AND METHODS
All procedures were approved by the University of Delaware Agricultural Animal Care and Use Committee.
Animals and Treatments
Six ruminally cannulated Holstein steers (~2 yr old, 646 ± 26 kg) were used in this experiment. Each steer was housed in a 2.4 × 6.4 m pen bedded with straw and wood shavings. Each pen contained a feed bin and automatic waterer.
Steers were given free choice access to a total mixed ration (TMR) formulated for lactating dairy cows. Fresh feed was provided once daily at 1000 h with any residual feed being weighed and discarded. As a percentage of DM, the ration contained 36.5% corn silage, 16.3% alfalfa silage, 17.4% ground corn grain, 7.2% soybean meal, 5.6% citrus pulp, 5.1% protected soybean meal, 3.2% canola meal, 2.3% dried distillers grains, 2.2% soybean hulls, 1.1% porcine blood meal, 0.5% sodium bicarbonate, 0.4% molasses, and 2.2% vitamin and mineral supplements.
The experiment was conducted as a crossover design with 14-d periods. On d 13 of each period, steers were infused abomasally (via tube through the rumen to the abomasum) with 0 (control) or 1 (Oligo) g of oligofructose/kg of BW (Beneo P95, Orafti Active Food Ingredients, Tienen, Belgium) in 1 L of water. Doses of oligofructose were administered immediately before feeding as a pulse dose (approximately 3 min per steer) using a hand pump. Infusion lines were inserted before the start of the experiment and removed after the completion of the experiment (Gressley et al., 2006) . Placement of each infusion line through the omasal orifice was manually verified before each infusion. Jugular catheters (BD Angiocath, Sandy, UT) were inserted on d 12 of each period. Catheters were flushed with heparinized saline (10 IU/mL, 0.9% NaCl) at 12-h intervals.
Sampling and Analyses
Individual feed samples were collected weekly and dried at 60°C for 48 h; DM percentage was used to adjust ration formulation for fluctuations in DM of ingredients. Total mixed ration samples were collected daily and frozen at −20°C until being composited by period. Composite samples were analyzed by wet chemistry at a commercial laboratory (Cumberland Valley Analytical Services Inc., Hagerstown, MD). Analyzed concentrations of CP, NDF, ADF, and starch averaged 17. 2, 29.6, 20.8, and 25 .7%, respectively. Individual TMR samples collected every 14 d were evaluated for particle size using the Penn State Particle Separator with 19.0-, 8.0-, and 1.18-mm sieve sizes (Kononoff et al., 2003) . On an as-fed basis, an average of 7, 32, 35, and 26% of the ration was found on the top sieve, second sieve, third sieve, and pan, respectively.
Blood samples (30 mL) were collected from the jugular catheters on d 13 of each period at 0 h (immediately before abomasal dosage) and at 3, 6, 9, 12, and 24 h after abomasal dosage. Blood was transferred into 10-mL serum and EDTA Vacutainer tubes (BD, Franklin Lakes, NJ). Plasma was isolated after centrifugation at 1,000 × g for 20 min at 4°C and stored at −20°C until analysis. Serum was allowed to clot for 3 h at room temperature, centrifuged at 1,000 × g for 30 min at 25°C, and stored at −20°C until analysis. Jugular catheters were removed each period immediately after the 24-h sampling.
Plasma samples were analyzed for BHBA, Cu, and haptoglobin, and serum samples were analyzed for urea N, NEFA, and serum amyloid A. Commercial colorimetric kits were used for quantification of urea N (Pointe Scientific Inc., Canton, MI), BHBA (Pointe Scientific Inc.), NEFA (Wako Diagnostics, Richmond, VA), serum amyloid A (Tridelta Development Ltd., Maynooth, Ireland), and haptoglobin (Tridelta Development Ltd.). All assays were read in 96-well plates using a Spectra MAX 190 plate reader (Molecular Devices, Sunnyvale, CA). For Cu analysis, 200 μL of plasma was transferred into 9.8 mL of 0.1% HNO 3 and centrifuged at 2,200 × g for 15 min at 4°C. The supernatant fluid was analyzed by inductively coupled plasma mass spectrometry (ICP-MS 7500 Series, Agilent Technologies, Santa Clara, CA).
At 0 and 6 h, an additional 3-mL blood sample was collected into a 3-mL syringe (BD) previously rinsed with heparinized saline (10 IU/mL, 0.9% NaCl) for pH measurement. Any air bubbles were removed, the syringe was capped with wax, and samples were transported on ice to New London Veterinary Center (Newark, DE) for pH analysis (IDEXX Vetstat Analyzer, Idexx Laboratories, Westbrook, ME). A maximum of 80 min elapsed between sampling and pH measurement.
Rectal temperatures, heart rate, and respiratory rate were measured at 0, 3, 6, 9, 12, 24, and 48 h after abomasal dosage. Fecal samples were collected from the rectum at 0, 3, 6, 9, 12, 24, and 48 h for measurement of pH, DM, fecal score, lactate, and VFA. Fecal pH was measured using a PH110 ExStik pH Meter (Extech, Waltham, MA). The meter was inserted directly into the feces, and pH was recorded after equilibration. Samples for fecal DM determination were frozen at −20°C and later thawed and dried for 48 h in a forced air oven at 60°C. Fecal score was visually evaluated according to Hulsen (2006) with 1 indicating extremely runny and 5 indicating extremely solid. For quantification of lactate and VFA, 25 ± 0.25 g of feces was combined with 10 mL of 2.06% H 2 SO 4 in a 50-mL conical tube. The tube was shaken vigorously for 10 s, and contents were squeezed through cheesecloth. The liquid was collected in a 15-mL conical tube and frozen at −20°C until analyzed.
Fecal lactate and VFA were determined according to the procedure established by Muck and Dickerson (1988) . Exactly 500 μL of each sample was combined with 500 μL of calcium hydroxide (3.5 M) and 250 μL of cupric sulfate plus an internal standard (0.63 M CuSO 4 and 0.046 M crotonic acid). Samples were placed in the refrigerator for 30 min before centrifugation at 9,400 × g for 15 min at 25°C. The supernatant fluid was poured into a fresh tube, and 12.5 μL of concentrated H 2 SO 4 was added. The sample was frozen, thawed, refrozen, and rethawed. This sample was centrifuged at 9,400 × g for 15 min at 25°C, and the supernatant fluid was analyzed by HPLC (Shimadzu Corporation, Columbia, MD). The liquid phase was a mixture of EDTA, H 2 SO 4 , and H 2 O.
Data were analyzed using the Mixed procedure (SAS Inst. Inc., Cary, NC). The model included the fixed effects of treatment, period, sequence, time, and the interaction of treatment × time and the random effects of steer within sequence and period × treatment × steer within sequence. Time was included as a repeated measure using the autoregressive covariance structure. For all models, residuals were evaluated for homogeneity of variance using the Univariate procedure of SAS. Residuals for serum amyloid A and plasma haptoglobin were not found to be normally distributed and were log-transformed before analysis to achieve normality. Significance was declared at P ≤ 0.05 and a trend at P ≤ 0.10.
RESULTS
Treatment did not affect DMI on the day of abomasal dosage (13.9 kg for control and 14.8 kg for Oligo, SEM = 0.5, P = 0.26) or the day after dosage (14.0 kg for control and 15.0 kg for Oligo, SEM = 1.6, P = 0.67). Blood pH at 6 h after the challenge was not affected by treatment (7.44 for both control and Oligo, SEM = 0.01, P = 0.63).
Main effects of treatment and time will be discussed only when their interaction is insignificant (P > 0.05). Treatment did not affect rectal temperature, respiratory rate, or serum or plasma concentrations of urea, BHBA, NEFA, Cu, serum amyloid A, or haptoglobin (Table 1) . A treatment × time interaction was observed for heart rate (P = 0.04) and was due to control being greater than Oligo at 3 h (98/min vs. 84/min; P = 0.01) but less than Oligo at 6 h (85/min vs. 100/min; P = 0.01). Time affected rectal temperature, respiratory rate, serum NEFA, and plasma haptoglobin (P ≤ 0.05) and tended to affect serum urea and Cu (P < 0.10; Table 1 ). Least squares means rectal temperature was 38.3°C at 0 h, increased to 38.7°C at 6 h, and gradually decreased to 38.3°C at 48 h. Respiratory rate ranged between 34 and 38/min at 0, 24, and 48 h and remained between 40 and 44/min from 3 to 12 h. Serum urea N was between 26 and 27 mg/dL at 0, 6, 9, and 12 h and between 35 and 36 mg/dL at 3 and 24 h. Serum NEFA decreased throughout the sampling period, with a maximum of 109 μEq/L at 0 h and a minimum of 70 μEq/L at 24 h. Plasma Cu was 1.62 mg/kg at 0 h, increased to 1.75 mg/kg at 3 h, and gradually decreased to 1.67 mg/kg at 24 h. The reverse-transformed least squares means for plasma haptoglobin ranged from 186 to 272 μg/mL from 0 to 12 h but was 593 μg/mL at 24 h.
Results for fecal variables are presented in Table 2 . Fecal pH was reduced by the Oligo treatment (P = 0.04). Although fecal pH was numerically reduced in Oligo steers at all times, the treatment effect was driven largely by differences at 6, 9, and 12 h (Figure 1 ). The magnitude of the difference in pH between treatments at the other times ranged from 0.02 to 0.22. Both fecal DM and fecal score were affected by treatment × time (P ≤ 0.001). Fecal DM for the Oligo treatment was 2.6 percentage units less than the control treatment at 6 h (P < 0.001) and was 1.3 and 1.5 percentage units greater at 9 and 12 h, respectively (P < 0.05; Figure   Table 1 . Effect of pulse dose abomasal dosage of 0 (control) or 1 (Oligo) g of oligofructose/kg of BW in Holstein steers on rectal temperature, heart and respiratory rates, and blood metabolites and acute phase proteins 1). Fecal score followed a similar pattern; Oligo was less than control at 6 and 9 h (P < 0.01) and tended to be greater than control at 24 h (P = 0.09). Qualitatively, feces from Oligo treated animals appeared foamy from 6 to 12 h. Additionally, mucin casts were visually apparent intermittently in fecal samples from Oligotreated animals but were not detected in fecal samples from control animals. Valerate was detected in only 37% of fecal samples and was therefore not analyzed statistically. Treatment × time effects were found for fecal concentrations of lactate, acetate, isovalerate, and total organic acids (P < 0.05) and tended to occur for propionate and butyrate (P < 0.10; Table 2; Figure 2 ). Fecal lactate increased in Oligo steers between 6 and 12 h; the difference between control and Oligo steers tended toward significance at 9 h (0.2 vs. 1.5 mM; P = 0.07) and was greatest at 12 h (0.5 vs. 5.2 mM; P < 0.001). For all VFA evaluated, concentrations remained relatively constant over time for control animals, and they were similar for control and Oligo steers at 0, 3, 24, and 48 h. In Oligo-treated steers, propionate, butyrate, and total organic acids were numerically reduced compared with control steers at 6 and 9 h but greater than control at 12 h. The reduction at 6 h for Oligo steers tended to be significant for butyrate (3.0 vs. 4.8 mM, P = 0.10). At 12 h after the abomasal dosage, fecal concentrations of acetate were 76 and 47 mM for Oligo and control, respectively, 15 and 11 mM for propionate, 6.8 and 4.0 mM for butyrate, and 104 and 64 mM for total organic acids (P < 0.05). Isovalerate in feces from Oligo steers differed substantially from the pattern of the other VFA. Isovalerate concentration was greater for the control than Oligo treatment at 6 (0.70 vs. 0.00 mM; P < 0.001), 9 (0.42 vs. 0.04 mM; P = 0.01), and 12 h (0.56 vs. 0.15 mM; P = 0.01).
DISCUSSION
We hypothesized that abomasal delivery of 1 g of oligofructose/kg of BW would increase intestinal fermentation and result in metabolic acidosis, metabolic disruption, and inflammation. Steers were fed a typical lactating cow ration because risk of increased hindgut fermentation increases with fermentable carbohydrate intake (Gressley et al., 2011) . We did not measure rumen pH, but we believe that SARA was unlikely due to the relatively low intake of steers compared with lactating cows.
Large pulse doses of ruminal oligofructose (13 to 21 g/kg of BW) have been shown to induce acute ruminal acidosis and laminitis in dairy heifers, with symptoms that included local and systemic inflammation and damage to the large intestine (Thoefner et al., 2004) . However, SARA is more prevalent on commercial operations than acute acidosis, and SARA is often accompanied with fecal signs of increased hindgut fermentation (Plaizier et al., 2008) . A relatively low pulse dose of abomasal oligofructose (1 g/kg of BW) was used in this experiment to moderately increase postruminal fermentation and mimic a short-term increase in hindgut fermentation similar to what is observed during SARA. In preliminary experiments utilizing increasing pulse doses of oligofructose, 1.0 g/kg of BW was the smallest dose to consistently trigger profuse, watery diarrhea, and cause animals to display signs of discomfort (data not shown). During this experiment, Oligo animals displayed signs of discomfort including increased standing, tail movement, and caudal head movement only for a short period of time, between 6 and 12 h.
Blood pH, rectal temperature, heart rate, and respiratory rate are altered by metabolic acidosis that can accompany acute ruminal acidosis (Owens et al., 1998; Krause and Oetzel, 2006) . Plasma NEFA concentrations also increased in acute acidosis in steers and sheep (Brown et al., 2000; Odongo et al., 2009 ). Counter to our hypothesis, none of those variables was affected by treatment in the current experiment, indicating that animals did not develop metabolic acidosis. We did not measure urine pH or blood base excess, both of which would have been more sensitive indicators of increased acid absorption from the gut than blood pH. However, Six steers were used in a crossover design with infusions administered on d 13 of each 14-d period.
2 Time = hour after oligofructose dosage (0, 3, 6, 9, 12, 24 , and 48 h).
we did measure blood β-BHBA concentration which we hypothesized would increase in response to increased acetate and butyrate absorption from the hindgut. An increase in plasma β-BHBA was not observed, further substantiating that acidosis did not occur during this experiment. There was also no treatment effect on BUN concentrations, which have been shown to decrease in lactating cattle in response to increased intestinal starch or fiber digestion and in sheep in response to metabolic acidosis (Reynolds et al., 2001; Gressley and Armentano, 2007; Odongo et al., 2009 ). Symptoms of SARA can include decreased intake and localized and systemic inflammation (Owens et al., 1998; Krause and Oetzel, 2006; Plaizier et al., 2008) . We had hypothesized that the Oligo treatment would reduce DMI and increase blood concentrations of inflammatory markers, but neither occurred. Increased osmolality of ruminal fluid and increased propionate absorption from the rumen both decrease DMI in cattle (Oetzel, 2003; Allen et al., 2009 ). The Oligo treatment may have increased both osmolality of hindgut contents and propionate absorption from the hindgut without affecting voluntary intake on the day of dosage. Haptoglobin and serum amyloid A are the primary acute phase protein mediators in cows, and blood Cu concentrations have also been shown to increase in some animal species during inflammation due to an increase in Cu-containing ceruloplasmin (Cray et al., 2009 ). Damage to intestinal epithelium as a consequence of increased hindgut fermentation associated with ruminal acidosis may contribute to systemic inflammation and laminitis (Oetzel, 2003; Thoefner et al., 2004; Crawford et al., 2007) . Most studies have shown that SARA induction in cattle increases blood concentrations of haptoglobin or serum amyloid A (Gozho et al., 2005 (Gozho et al., , 2006 Khafipour et al., 2009 ), but one study found no change in blood haptoglobin or Cu (Gozho et al., 2007) . The lack of treatment effects on blood inflammatory markers or intake in the current study further indicates that acidosis and inflammation were not induced by the Oligo treatment. However, we only measured shortterm responses to a pulse dose, and long-term effects of increased hindgut fermentation cannot be determined from this experiment. Additionally, we measured systemic but not local inflammatory response indicators, and it is possible that local inflammation occurred without triggering a systemic response.
Oligo-treated animals developed diarrhea and feces that contained gas bubbles and mucin casts, all of which are used in the field as indicators of increased hindgut fermentation that accompanies SARA (Hall, 2002; Plaizier et al., 2008) . More quantitative indicators of increased hindgut fermentation observed in this trial included reduced fecal pH and increased fecal VFA and lactate concentrations. Fecal pH at 6, 9, and 12 h averaged 7.06 in control and 6.62 in Oligo-treated steers. The magnitude of this difference was similar to that observed in cows given 1.2 kg/d (equivalent to 1.6 g of DM/kg of BW) continuous abomasal wheat Figure 1 . Effect of pulse dose abomasal delivery of 0 (control; ▬•▬) or 1 (Oligo; --□--) g of oligofructose/kg of BW in Holstein steers on fecal pH, fecal DM percentage, and fecal score. Six steers were used in a crossover design with infusions administered on d 13 of each 14-d period. Dosages were administered immediately after the 0-h sample. Fecal score measured from 1 (liquid) to 5 (solid). *Oligo differs from control (P < 0.05). †Oligo differs from control (P < 0.10). Error bars indicate the SE of the difference for treatment × time. Figure 2 . Effect of pulse dose abomasal delivery of 0 (control; ▬•▬) or 1 (Oligo; --□--) g of oligofructose/kg of BW in Holstein steers on fecal concentrations of lactate, acetate, propionate, butyrate, isovalerate, and total organic acids (lactate + acetate + propionate + butyrate + isobutyrate + isovalerate). Six steers were used in a crossover design with infusions administered on d 13 of each 14-d period. Dosages were administered immediately after the 0-h sample. Concentrations are expressed as millimoles per liter of fecal liquid. *Oligo differs from control (P < 0.05). †Oligo differs from control (P < 0.10). Error bars indicate the SE of the difference for treatment × time.
starch infusions and in horses fed 3 g of oligofructose/ kg of BW (Reynolds et al., 2001; Crawford et al., 2007) . However, cows abomasally infused with 5 g of cornstarch/kg of BW and horses fed 10 g of oligofructose/ kg of BW experienced a severe decline in fecal pH (decline from ~7 to <5) that was accompanied by illness including laminitis, dramatically decreased intake, and intestinal damage (Bissell, 2002; Milinovich et al., 2006) . The slight decline in fecal pH with the Oligo treatment and the lack of treatment effects on intake or blood variables suggests that the Oligo treatment did not cause acidotic conditions that damaged large intestinal mucosa. The lack of these effects could have been due to the use of oligofructose instead of starch, the relatively small oligofructose dose used, or the short duration of exposure of the intestines to oligofructose.
Whereas the decline in rumen pH during acute acidosis is typically attributed to an accumulation of lactic acid, SARA often occurs with an increase in total VFA and not lactate (Stone, 2004; Krause and Oetzel, 2006) ; however, ruminal lactic acid also has been found to increase transiently to up to 40 mM during SARA Oetzel, 2005, 2006) . In the current experiment, fecal concentrations of lactate and VFA were increased at 12 h after oligofructose dosage. Hyperosmolality of rumen fluid during SARA and acute ruminal acidosis contributes to epithelial damage and local inflammation (Owens et al., 1998; Krause and Oetzel, 2006) . Although osmolality of feces was not measured in this study, increased fecal VFA in response to the Oligo treatment suggests that osmolality of intestinal digesta may have been increased. Of the concentration difference in total acetate, propionate, and butyrate at 12 h between the Oligo and control treatments, 81% was due to increased acetate, 11% to propionate, and 8% to butyrate. In vitro fermentation of fructans by fecal or cecal inoculum typically generates about 65% acetate, 20% propionate, and 15% butyrate (Nyman, 2002; Awati et al., 2006) . The difference between in vitro VFA production ratios and those observed in feces in the current study may reflect decreased fractional VFA absorption rates from intestines of acetate compared with propionate and butyrate (Myers et al., 1967) , though these differences become less pronounced as digesta pH nears neutrality (Myers et al., 1967; Dijkstra et al., 1993) .
Although the ideal location for the oligofructose delivery would have been the cecum or large intestine, abomasal dosages were administered because they were less invasive, requiring only ruminally cannulated animals. The retention time of water in the digestive tract of steers is approximately 2 h in the abomasum, 4 h in the small intestine, and 9 h in the large intestine (Arnold and Trenkle, 1986 ). In the current study, steers given the Oligo treatment had diarrhea and feces with less DM content at 6 h, suggesting that the oligofructose increased gut transit time. This may have been due to the osmotic effect of oligofructose drawing water from the body into digesta. As reviewed by Roberfroid and Delzenne (1998) , transit time through the digestive tract was reduced in rats and humans fed oligofructose. Decreased transit time in the current study would explain why reduced DM in feces was observed before the decrease in pH and increase in VFA that were indicative of increased hindgut fermentation. The control treatment in the present study was abomasal water, which would not have induced similar osmotic effects; an additional control treatment consisting of water containing a nonabsorbable and nonfermentable substance with similar osmotic effects would have helped to differentiate such effects. The decreased retention times in the abomasum and small intestine of Oligo-treated steers could have reduced digestion of feed substrates, increased fermentable carbohydrate flow to the large intestine, and contributed to the increase in hindgut fermentation. Despite the cause of increased hindgut fermentation, the Oligo treatment did not result in symptoms of acidosis, metabolic disruption, or inflammation.
Although starch is the most likely substrate to increase large intestinal fermentation in commercial dairy cattle (Hoover, 1978) , this model used oligofructose, composed of linear β-(1→4) linked fructose units. Oligofructose is a carbohydrate that is readily fermented by microorganisms, but not digested by endogenous enzymes, allowing for the postruminal delivery of a precise amount of fermentable substrate to the intestines. Several studies have noted similarities between starch and oligofructose fermentation. Ruminal populations of streptococci and lactobacilli increase during starch-induced ruminal acidosis (Owens et al., 1998) , and similar shifts have been found in vivo and in vitro in horse intestinal microbial populations in response to feeding oligofructose (Bailey et al., 2003; Milinovich et al., 2006) . In vitro studies using horse fecal or piglet cecal inoculum have found similar VFA production and OM disappearance after 24 h for both fructans and starch, although initial rates of gas production and pH decline were greater for fructans (Bailey et al., 2002; Awati et al., 2006) . Finally, Marounek et al. (1988) conducted in vitro studies utilizing rumen fluid and concluded that fructan and starch fermentation rates and VFA profiles were similar, though a direct comparison was not conducted.
In conclusion, pulse dose abomasal delivery of 1 g of oligofructose/kg of BW increased hindgut fermentation but did not result in metabolic acidosis, metabolic disruption, or inflammation. There were no effects of treatment on intake, temperature, heart rate, respiratory rate, or blood variables. The osmotic effect of the dosed oligofructose may have increased gut transit time and contributed to the increase in hindgut fermentation. Although some of the negative effects of SARA on animal health and performance may be due to the increase in hindgut fermentation that often accompanies SARA, no such negative effects were observed in this study. Lack of effects may be attributed to the short-term exposure of the intestines to oligofructose, the relatively low dose of oligofructose used, or the use of oligofructose delivered to the abomasum instead of starch delivered to the large intestine.
